Organogenesis Holdings (ORGO) Other Non-Current Liabilities (2017 - 2026)

Organogenesis Holdings' Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Other Non-Current Liabilities rose 65.66% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $1.5 million, a 65.66% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 33.45% from the prior year.
• Other Non-Current Liabilities advanced to $1.5 million in Q1 2026 per ORGO's latest filing, from $1.2 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.0 million in Q2 2025 and bottomed at $894000.0 in Q4 2024.
• The 5-year median for Other Non-Current Liabilities is $1.2 million (2023), against an average of $1.4 million.
• Across the five-year window, Other Non-Current Liabilities plunged 71.27% in 2022 and soared 138.33% in 2025, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $1.1 million in 2022, then advanced by 8.11% to $1.2 million in 2023, then retreated by 26.3% to $894000.0 in 2024, then jumped by 33.45% to $1.2 million in 2025, then gained by 24.56% to $1.5 million in 2026.
• Per Business Quant, the three latest ORGO Other Non-Current Liabilities figures stand at $1.5 million (Q1 2026), $1.2 million (Q4 2025), and $2.5 million (Q3 2025).